Skip to content
Polls conducted by YouGov and Wakefield Research show the majority of Americans want the government to invest in better pandemic preparedness in the wake […]
Polls show Americans want better pandemic preparedness Read More »
On April 3, the Biden administration released a National Cancer Plan that seeks to coordinate government, research, and the biotech industry to cut cancer deaths
National Cancer Plan outlines government cooperation with biotech industry Read More »
Scientists using the CRISPR-Cas9 gene-editing technology say they can treat mice to reverse the deterioration that takes place after a heart attack. Their research
CRISPR post-heart attack therapy suggests new uses for gene editing Read More »
The “benefits” pharmacy benefit managers (PBMs) once provided have been lost, as these organizations now mostly help themselves while driving up drug prices, said
Senate hearing looks at what went wrong with PBMs Read More »
The threat of expanding intellectual property waivers by the World Trade Organization (WTO) dampens investment in research, Biotechnology Innovation Organization’s (BIO) Chief Policy Officer
BIO opposes extension of WTO IP waiver in federal hearing Read More »
The lessons of COVID-19 were unequivocal: Pandemic preparedness is key to national security. According to a national poll conducted by the Biotechnology Innovation Organization
Voters want better pandemic preparedness Read More »
The impact of drug price controls on innovation, market distortions caused by pharmacy benefit managers (PBMs), and the importance of accelerated approval came up
House 2024 health budget hearings touch on price controls and PBMs Read More »
On March 27, heads of the Food and Agriculture Organization (FAO), the U.N. Environment Programme (UNEP), the World Health Organization (WHO), and the U.N.-backed
U.N.’s ‘One Health’ approach aims to unite against zoonotic diseases Read More »
Legislation that has been reintroduced in the Senate and has the support of the Biotechnology Innovation Organization (BIO) is set to enhance research, an
R&D in biotech gets a boost with reintroduced bill Read More »
The Accelerated Approval pathway was established by the U.S. Food and Drug Administration (FDA) in the 1990s to boost R&D for HIV/AIDS, and the
I am BIO Podcast: Accelerated Approval, accelerating hope Read More »
